Effects of Empagliflozin on Cardiac Microvasculature and Insulin Sensitivity in Subjects With Type 2 Diabetes
NCT04203927
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Type2 Diabetes
Insulin Sensitivity
Interventions
DRUG:
Empagliflozin 25 MG
Sponsor
University of Virginia
Collaborators
[object Object]